Rituximab and RASi in Patients with IgAN

Clinical trial NCT04525729 · COMPLETED

Trial details

NCT number: NCT04525729
Sponsor: Nan Chen,MD
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

IgA Nephropathy

Start date: 2020-07-01
Primary completion: 2024-03-30
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.